NSE filing, NSE: GODREJAGRO. Summary written from the filing by ALFA Finder's alert engine.
Godrej Agrovet Ltd: key numbers
- Share price
- ₹579.00
- Market cap
- ₹11,141 Cr
- Revenue (annual)
- ₹10,233 Cr
- Net profit (annual)
- ₹472.8 Cr
- P/E (TTM)
- 24.9×Sector 26.8×
- Promoter holding
- 67.72%-0.02% QoQ
- FII holding
- 6.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godrej Agrovet Ltd
All →Godrej Agrovet Board Meeting Date
Godrej Agrovet Ltd has notified a board meeting on November 6, 2026 to approve standalone and consolidated unaudited results for the quarter and half year ended September 30, 2026. The filing is a meeting intimation only, with no results figures disclosed yet.
Godrej Agrovet Other Announcement
Godrej Agrovet Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory norms.
Godrej Agrovet Debt & Borrowing: ₹50 Cr
Godrej Agrovet Limited successfully redeemed its Commercial Paper series GAVLCP/26-27/16 on October 15, 2026. The company paid a maturity amount of ₹50 Crore in accordance with regulatory requirements.
- Value
- ₹50.00 Cr
Godrej Agrovet Debt & Borrowing: ₹150 Cr
Godrej Agrovet fixed record dates for two commercial papers totaling ₹150 Crore maturing in November 2026. The CPs are listed on NSE under ISINs INE850D14VS5 and INE850D14WD5.
- Value
- ₹150.0 Cr
Godrej Agrovet Debt & Borrowing: ₹25 Cr
Godrej Agrovet Limited has completed the redemption of Commercial Paper amounting to Rs. 25 Crore on the maturity date.
- Value
- ₹25.00 Cr
Godrej Agrovet Debt & Borrowing: ₹50 Cr
Godrej Agrovet Limited has successfully redeemed Commercial Papers worth ₹50 Crore upon maturity. This payment confirms the company's commitment to meeting its debt obligations.
- Value
- ₹50.00 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.